search
Back to results

A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting

Primary Purpose

Urinary Incontinence

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Care planning using TENA Identifi sensor wear data
Care planning without using TENA Identifi sensor wear data
Sponsored by
Insight Therapeutics, LLC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urinary Incontinence focused on measuring urinary incontinence, nursing home

Eligibility Criteria

55 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Males or females 55 years of age or older with stable clinical status
  2. Long-stay status (more than 90 days)
  3. Ambulatory and able to use a toilet either independently or with assistance
  4. Minimum Data Set (MDS) Level 1 (occasionally), 2 (frequently) or 3 (always) rating of incontinence
  5. Currently wearing disposable briefs for urinary incontinence

Exclusion Criteria:

  1. Chronically bed-bound (MDS G0110A rating 8)
  2. MDS self-performance rating of 4 (total dependence) for toilet use
  3. Fecal incontinence (MDS H0400 rating 0)
  4. Use of urinary appliance such as catheters or ostomies (MDS H0100 Z)
  5. Private duty nurse care
  6. Residents who tear at clothing or disposable undergarments
  7. Current urinary tract infection receiving treatment
  8. Current diarrhea receiving treatment
  9. Residents who are not likely to benefit from a toileting plan based on assessment of nursing staff

Sites / Locations

  • Chesapeake Health & Rehabilitation Center
  • Norfolk Health & Rehabilitation Center
  • Insight Therapeutics, LLC
  • Westminster-Canterbury on Chesapeake Bay
  • Beth Sholom Village

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

TENA Identifi with sensor wear data

TENA Identifi without sensor wear data

Arm Description

All individuals in this arm will receive care planning using TENA Identifi sensor wear data

All individuals in this arm will receive care planning without using TENA Identifi sensor wear data

Outcomes

Primary Outcome Measures

Wet Events Per 24 Hours
Comparison of the number of wet events per 24 hours as recorded by TENA Identifi, intervention versus control

Secondary Outcome Measures

Time Wet Per 24 Hours
Comparison of the amount of time wet per 24 hours as recorded by TENA Identifi, intervention versus control
Number of Brief Changes Per 24 Hours
The number of brief changes per 24 hours, intervention versus control

Full Information

First Posted
July 3, 2017
Last Updated
July 25, 2019
Sponsor
Insight Therapeutics, LLC
Collaborators
Essity Hygiene and Health AB
search

1. Study Identification

Unique Protocol Identification Number
NCT03209570
Brief Title
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Official Title
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
October 19, 2017 (Actual)
Primary Completion Date
August 11, 2018 (Actual)
Study Completion Date
August 11, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Insight Therapeutics, LLC
Collaborators
Essity Hygiene and Health AB

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to prospectively compare a standard of care manual toileting protocol (e.g., "check and change" strategy) to toileting patterns recorded by the TENA Identifi system in identifying incontinence patterns and events, and, whether such data differentially improve a care planning strategy, nursing effort, product use, and wet-time for urinary incontinence.
Detailed Description
Urinary incontinence in nursing homes influences resident dignity and quality of life. It also drives significant use of healthcare resources, including time and caregiver assistance, and costs of care. Various toileting programs are used to address urinary incontinence, including habit training, bladder training, prompted voiding, and check and change procedures. Clinical trials have found that 33% to 60% of residents either became continent or reduced the frequency of incontinence episodes to less than one per day with the introduction of a prompted voiding program. There are several drawbacks to current programs. Manually recorded wet checks do not identify when incontinence occurs, only when wetness is detected, reducing the precision of time of incontinence to the window of time between checks. Nursing home staff create individualized care plans for each resident, based on standard check and change procedures, but poor precision in ascertaining timing and quantity of incontinence episodes can contribute to less frequent resident toileting or changing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence
Keywords
urinary incontinence, nursing home

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
49 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TENA Identifi with sensor wear data
Arm Type
Experimental
Arm Description
All individuals in this arm will receive care planning using TENA Identifi sensor wear data
Arm Title
TENA Identifi without sensor wear data
Arm Type
Active Comparator
Arm Description
All individuals in this arm will receive care planning without using TENA Identifi sensor wear data
Intervention Type
Other
Intervention Name(s)
Care planning using TENA Identifi sensor wear data
Intervention Description
All individuals in this arm will receive TENA Identifi sensor wear and will have data available for care planning.
Intervention Type
Other
Intervention Name(s)
Care planning without using TENA Identifi sensor wear data
Intervention Description
All individuals in this arm will receive TENA Identifi sensor wear but the sensor wear data will not be used for care planning.
Primary Outcome Measure Information:
Title
Wet Events Per 24 Hours
Description
Comparison of the number of wet events per 24 hours as recorded by TENA Identifi, intervention versus control
Time Frame
6 days
Secondary Outcome Measure Information:
Title
Time Wet Per 24 Hours
Description
Comparison of the amount of time wet per 24 hours as recorded by TENA Identifi, intervention versus control
Time Frame
6 days
Title
Number of Brief Changes Per 24 Hours
Description
The number of brief changes per 24 hours, intervention versus control
Time Frame
6 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males or females 55 years of age or older with stable clinical status Long-stay status (more than 90 days) Ambulatory and able to use a toilet either independently or with assistance Minimum Data Set (MDS) Level 1 (occasionally), 2 (frequently) or 3 (always) rating of incontinence Currently wearing disposable briefs for urinary incontinence Exclusion Criteria: Chronically bed-bound (MDS G0110A rating 8) MDS self-performance rating of 4 (total dependence) for toilet use Fecal incontinence (MDS H0400 rating 0) Use of urinary appliance such as catheters or ostomies (MDS H0100 Z) Private duty nurse care Residents who tear at clothing or disposable undergarments Current urinary tract infection receiving treatment Current diarrhea receiving treatment Residents who are not likely to benefit from a toileting plan based on assessment of nursing staff
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stefan Gravenstein, MD, MPH
Organizational Affiliation
Brown University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
H Edward Davidson, PharmD, MPH
Organizational Affiliation
Insight Therapeutics, LLC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chesapeake Health & Rehabilitation Center
City
Chesapeake
State/Province
Virginia
ZIP/Postal Code
23320
Country
United States
Facility Name
Norfolk Health & Rehabilitation Center
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23504
Country
United States
Facility Name
Insight Therapeutics, LLC
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23510
Country
United States
Facility Name
Westminster-Canterbury on Chesapeake Bay
City
Virginia Beach
State/Province
Virginia
ZIP/Postal Code
23451
Country
United States
Facility Name
Beth Sholom Village
City
Virginia Beach
State/Province
Virginia
ZIP/Postal Code
23464
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
7715062
Citation
Ouslander JG, Schnelle JF, Uman G, Fingold S, Nigam JG, Tuico E, Bates-Jensen B. Predictors of successful prompted voiding among incontinent nursing home residents. JAMA. 1995 May 3;273(17):1366-70.
Results Reference
background
PubMed Identifier
20631404
Citation
Omli R, Skotnes LH, Romild U, Bakke A, Mykletun A, Kuhry E. Pad per day usage, urinary incontinence and urinary tract infections in nursing home residents. Age Ageing. 2010 Sep;39(5):549-54. doi: 10.1093/ageing/afq082. Epub 2010 Jul 14.
Results Reference
background
Links:
URL
https://prd-medweb-cdn.s3.amazonaws.com/documents/cqa/files/Incontinence%20Management/Vanderbilt%20Incontinence%20Management%20Module.pdf
Description
urinary incontinence training module; includes description of standard of care incontinence assessment for nursing home residents

Learn more about this trial

A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting

We'll reach out to this number within 24 hrs